LA49 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)
Pill with imprint LA49 is Blue, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Laurus Labs Limited.
Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LA49
Related Images for "LA49"
More about emtricitabine / tenofovir
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 28 Reviews
- Drug class: antiviral combinations
- Emtricitabine and tenofovir
- Emtricitabine and Tenofovir Disoproxil Fumarate
- Emtricitabine and tenofovir (Advanced Reading)